• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Public Health

Inflated media health news coverage linked to press release exaggeration

byRavi Shah
December 17, 2014
in Public Health
Reading Time: 3 mins read
AAP guidelines for pneumococcal vaccination in high-risk groups released
Share on FacebookShare on TwitterShare on LinkedIn

1. News reporting on scientific studies is often exaggerated and implies greater causality and inference than the research actually finds.

2. There was a direct link between over exaggeration in press releases coming from the research institutions and news reporting inflation.

Evidence Rating Level: 2 (Good)           

Study Rundown: The relationship between published research and the media is one mediated through press releases and news articles. There is often miscommunication of the actual research findings with exaggeration of the results’ implications. This study aimed to elucidate the level at which this disconnect occurs and how findings are misrepresented in the media. It was found that press releases of research conducted at the 2011 Russell Group Universities, the top 20 research universities in the UK, in fact overstated causation, correlation, and/or impact about 40% of the time. News stories based on exaggerated press releases were about six times more likely to have exaggerated claims. Interestingly, exaggerated press releases did not relate to increased news uptake, placing a large portion of the sensationalism blame on the press releases themselves.

While this study has its limitations, it presents much opportunity for growth and improvement. It is of importance that the medical profession recognize that it may itself be perpetuating a culture of exaggeration. While, as this study found, caveats and justifications are rarely reported in press releases, their presence did not affect new coverage and uptake.

Click to read the study in the BMJ

RELATED REPORTS

Stool biomarkers may be effective in the evaluation of necrotizing enterocolitis in preterm infants

Tarlatamab plus durvalumab improved survival versus durvalumab alone in extensive-stage small cell lung cancer, Amgen reports in interim phase 3 results

Click to read an accompanying editorial in the BMJ

Relevant Reading: Importance of the lay press in the transmission of medical knowledge to the scientific community

In-Depth [retrospective analysis]: This study, an analysis of research and the subsequent reporting of findings in the media, was conducted using 462 press releases and 668 news stories of research published at the 20 2011 Russell Group University in the UK. The authors analyzed the relationship between the actual findings in the research and news reporting and looked to see if there were mention of caveats and justifications. It was found that 40% (CI95% bootstrapped 33%-46%) of press releases were exaggerated in the form of overstated correlation/causation, inflated translatability of non-human studies to humans, and direct advice being inferred from the research. The odds ratio for news being exaggerated was 6.5 fold (CI95% 3.5-12.4) higher when the press release was exaggerated. Approximately 47% of non-human study news stories contained inflated inferences for human application. There was no significant association between exaggeration of press releases and news uptake.

More from this author: Affordable Care Act: Improved health, lower costs in youth with dependent coverage, No difference in kidney function with “on” vs “off-pump” coronary bypass graft, Durability of cardiology practice guidelines varies with level of evidence, Oncogenic drivers effective at guiding lung adenocarcinoma therapy, Genetic factors account for half of complete risk of autism spectrum disorders, Increased maternal BMI linked to higher fetal, neonate, and infant mortality

Image: PD

©2014 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Previous Post

Engineered stem cells mitigate liver damage caused by radiation [PreClinical]

Next Post

Oral antibiotics may be noninferior to intravenous in pediatric acute osteomyelitis

RelatedReports

An incubator for preterm infants, alongside monitoring equipment and oxygen delivery components.
Gastroenterology

Stool biomarkers may be effective in the evaluation of necrotizing enterocolitis in preterm infants

October 26, 2026
An illustration showing human lungs, a tray with sampling devices, and a teal awareness ribbon, representing lung cancer diagnostics and lymph node sampling.
2MM Trial Briefs

Tarlatamab plus durvalumab improved survival versus durvalumab alone in extensive-stage small cell lung cancer, Amgen reports in interim phase 3 results

October 26, 2026
Illustration showing the lungs with a tumor, a vial representing medication, and surgical tools, indicating lung cancer treatment involving toripalimab.
2MM Trial Briefs

Sacituzumab tirumotecan improved overall survival versus platinum chemotherapy in company-reported final phase 3 results

October 25, 2026
An illustration of the pancreas, highlighting cancer cells related to pancreatic cancer and molecular structures, indicating targeted research in oncology.
2MM Trial Briefs

Camupepimut did not improve disease-free survival versus observation in pancreatic cancer in the randomized phase 2 AMPLIFY-7P trial

October 25, 2026
Next Post
Oral antibiotics may be noninferior to intravenous in pediatric acute osteomyelitis

Oral antibiotics may be noninferior to intravenous in pediatric acute osteomyelitis

Classics Series, Landmark Trials in Medicine

Most ovarian cysts resolve, sonographic surveillance recommended [Classics Series]

Imaging of atherosclerotic inflammation possible with fluorine MRI

Imaging of atherosclerotic inflammation possible with fluorine MRI

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Stool biomarkers may be effective in the evaluation of necrotizing enterocolitis in preterm infants
  • Tarlatamab plus durvalumab improved survival versus durvalumab alone in extensive-stage small cell lung cancer, Amgen reports in interim phase 3 results
  • Sacituzumab tirumotecan improved overall survival versus platinum chemotherapy in company-reported final phase 3 results
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.